Using modified antigenic sequences to develop cancer vaccines: are we losing the focus?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 15578104.
- Also identified by PMC identifier 529422.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Are short synthetic peptides the key to developing cancer vaccines? And what are the obstacles in the way?
Medical subject headings
- Antigens, Neoplasm
- Cancer Vaccines